COMETRIQ

CABOZANTINIB · Exelixis, Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for COMETRIQ, covering 2012-11-29 to 2026-07-22. Get the full timeline:

Most recent: EMA Authorised: Cometriq (cabozantinib) — Ipsen Pharma